Pre-diabetes, insulin resistance, inflammation and CVD risk.
about
Association between cardiac autonomic function, oxidative stress and inflammatory response in impaired fasting glucose subjects: cross-sectional study'Maintaining balance and harmony': Javanese perceptions of health and cardiovascular disease.Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus.Plasma protein profiling reveals protein clusters related to BMI and insulin levels in middle-aged overweight subjectsAssociation of nitric oxide synthase 3 gene polymorphism with the risk of type 2 diabetesImmunoglobulin E and mast cell proteases are potential risk factors of human pre-diabetes and diabetes mellitus.Interaction between the NOS3 gene and obesity as a determinant of risk of type 2 diabetes: the Atherosclerosis Risk in Communities studySoluble CD40 ligand levels in otherwise healthy subjects with impaired fasting glucoseGout epidemiology: results from the UK General Practice Research Database, 1990-1999.Insulin glargine reduces carotid intimal hyperplasia after balloon catheter injury in Zucker fatty rats possibly by reduction in oxidative stress.Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease.Diabetes and pre-diabetes are associated with cardiovascular risk factors and carotid/femoral intima-media thickness independently of markers of insulin resistance and adiposity.Position of fixed-dose combinations containing an AT(1)-receptor blocker and a thiazide diuretic.Peripheral fat loss and decline in adipogenesis in older humans.Effect of rosuvastatin dose-loading on serum sLox-1, hs-CRP, and postoperative prognosis in diabetic patients with acute coronary syndromes undergoing selected percutaneous coronary intervention (PCI).Type II diabetes mellitus and cardiovascular risk factors: Current therapeutic approachesCD4/CD8 Ratio Predicts Peripheral Fat in HIV-Infected Population.Reduced 10-year risk of coronary heart disease in patients who participated in a community-based diabetes prevention program: the DEPLOY pilot study.Impaired retinal vasodilator responses in prediabetes and type 2 diabetes.Association of Traditional Chinese Medicine Therapy and the Risk of Vascular Complications in Patients With Type II Diabetes Mellitus: A Nationwide, Retrospective, Taiwanese-Registry, Cohort Study.Carotid Artery Intima Media Thickness and HsCRP; Predictors for Atherosclerosis in Prediabetic Patients?The effect of hydroxychloroquine on glucose control and insulin resistance in the prediabetes condition.Associations between branched chain amino acid intake and biomarkers of adiposity and cardiometabolic health independent of genetic factors: A twin study.Prevalence and clinical characteristics of the metabolic syndrome in middle-aged Korean adults.Models for estimating the metabolic syndrome biological age as the new index for evaluation and management of metabolic syndrome.Effects of atorvastatin 10 mg/d on insulin resistance: A 12-week, open-label study in hyperlipidemic patients.Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus.Diabetes is an inflammatory disease: evidence from traditional Chinese medicines.Ginseng and diabetes: the evidences from in vitro, animal and human studies.Anti-diabetic potential of Panax notoginseng saponins (PNS): a review.Hyperglycaemia, oxidative stress and inflammatory markers.Serum C-reactive protein level and prediabetes in two Asian populations.Platelet aggregation is not enhanced in patients with prediabetes.Pioglitazone has anti-inflammatory effects in patients with Type 2 diabetes.Endothelial Dysfunction in Type 2 Diabetes Mellitus.Pathophysiology and long-term management of the metabolic syndrome.Relationship between insulin resistance assessed by HOMA-IR and exercise test variables in asymptomatic middle-aged patients with type 2 diabetes.
P2860
Q28481738-A8B01C57-F343-456F-A551-2D216D60D3D9Q30388431-4F31E783-DCD2-4502-A4FB-B3052355B2E1Q33706621-ACE05DF8-D386-49CA-9AC8-2DB61DDCCFA8Q33784462-DF01CB34-6894-4265-8ED1-56EABF63B7B6Q33857620-64C3C6A1-93D6-4DA2-9EAA-3C0B68125403Q34110586-7CB34580-D882-4012-AFEF-331556E917BBQ35053164-09142DE7-04D5-4979-BC26-95D6A4D938E7Q35161461-B3BC6064-8C9E-4817-9383-F3BAC81196B1Q35555160-5C236336-26FF-4AC5-B4FD-EF31F4A712F8Q35565342-4592E5E8-8784-4BDF-AA8E-2F35145D56C2Q35588998-D2AAC44B-692E-4C7A-B9FD-4C2B56BAEEB6Q36287967-868D4CB5-BF17-414A-823E-91254FEA7483Q36364949-6319FD01-17A2-4572-B7F1-BB9564FB4811Q36492251-1FEB322C-3276-4669-9FC3-31B28795FEACQ36493187-93D452DC-1CC4-426D-B182-FEEF3AAFAF5CQ36608474-9BA4518C-2B7E-483E-AA5A-D6BACB505F8AQ36813651-13AE6395-6F40-438C-89D0-B14A374FF645Q37105149-29970E8B-3E99-44A0-BAAD-B49A00A712A9Q37110310-2CC5BB01-9AC7-409D-A26D-D46F741FC6AFQ37204963-1A6CE5B9-26BF-4ED6-B825-739056B9DB55Q37257848-17778AE4-21F7-44E5-BE15-E05027A121DCQ37261219-9BA890F8-1838-48DC-9680-B4F5B95ED317Q37356958-C2CDBFEA-6A65-41DB-96AC-D1718C4A6FA5Q37475918-F0388F18-D214-40CD-9ED8-CE6195F71BB4Q37629587-1EED8C88-7643-485F-BC48-4571729D997DQ37663572-2CAE733A-B7B7-4D65-87C1-1EBAB99ECEEBQ37773162-93B1120B-8189-45CD-A8AD-BA19DF7999A1Q37825944-FBFF0CD7-48E9-442C-B5C1-7F599536C416Q38110276-A81D2ED2-20F7-4D66-8E51-550731F70B9AQ38121039-4531988C-EBD3-490F-B310-A660E5DB7951Q38918375-D5917C87-968C-497C-94D0-22FAA024061EQ39789739-F689B823-D731-4CFC-ACCA-829539A99E06Q43724690-73E712AD-FD09-41B6-B0FD-D1CD2571DB34Q51469866-92BE23D2-B6D9-409A-AAA7-624F4635415FQ52674867-1ED3A570-00C4-46CF-B608-922D6DB1374CQ53872253-BAFF1AD7-684C-4E50-ABB9-799CD7AC532CQ53890133-9259D1D3-A1B1-4505-BA3F-BDB428A8AD0F
P2860
Pre-diabetes, insulin resistance, inflammation and CVD risk.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Pre-diabetes, insulin resistance, inflammation and CVD risk.
@ast
Pre-diabetes, insulin resistance, inflammation and CVD risk.
@en
type
label
Pre-diabetes, insulin resistance, inflammation and CVD risk.
@ast
Pre-diabetes, insulin resistance, inflammation and CVD risk.
@en
prefLabel
Pre-diabetes, insulin resistance, inflammation and CVD risk.
@ast
Pre-diabetes, insulin resistance, inflammation and CVD risk.
@en
P1476
Pre-diabetes, insulin resistance, inflammation and CVD risk.
@en
P2093
Steven M Haffner
P304
P356
10.1016/S0168-8227(03)00122-0
P478
61 Suppl 1
P577
2003-07-01T00:00:00Z